吉港中医药专家长春交流 携手推动人参产业国际化

Core Viewpoint - The visit of Hong Kong Chinese medicine experts to Jilin aims to enhance the internationalization of the Changbai Mountain ginseng industry and promote collaboration between Jilin and Hong Kong in traditional Chinese medicine [1][2][3]. Group 1: Industry Overview - Jilin Province is a major producer of ginseng, accounting for approximately 85% of China's total ginseng production and 70% of the world's total production [2]. - The total industrial chain output value of the ginseng industry in Jilin is expected to exceed 100 billion yuan by 2025, with a year-on-year growth of over 30% [2]. Group 2: Internationalization Efforts - Jilin Province is actively promoting the internationalization of the "Changbai Mountain Ginseng" brand and is establishing platforms for international market connections [2]. - A promotional event for Changbai Mountain ginseng is scheduled to take place in Hong Kong in May 2025, aimed at fostering resource sharing and mutually beneficial cooperation [2]. Group 3: Collaboration and Research - The visit by Hong Kong experts is seen as a continuation of previous promotional efforts and aims to deepen exchanges and promote development between Jilin and Hong Kong [2][3]. - The Hong Kong Chinese medicine community is expected to leverage its advanced research capabilities to assist Jilin's research institutions in expanding studies related to ginseng [2][3].